INHIBIKASE THERAPEUTICS INC (IKT) Institutional Shareholders
INHIBIKASE THERAPEUTICS INC (IKT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $238.20M in IKT holdings during the latest filing period.
Sands Capital Alternatives, Llc is currently the largest disclosed institutional shareholder of IKT tracked by InsiderSet, reporting ownership valued at approximately $26.43M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $29.94M, representing an estimated gain of +13.30% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed IKT value among the investors covered in this analysis. Major shareholders include Sands Capital Alternatives, Llc, Soleus Capital Management, L.P., Trails Edge Capital Partners, Lp, and several other long-term asset managers with concentrated positions in INHIBIKASE THERAPEUTICS INC (IKT).
This page ranks the largest institutional IKT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
106
Total Reported Value
$238.20M
Largest Holder
Sands Capital Alternatives, Llc
Largest Position
$26.43M
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
128
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Sands Capital Alternatives, Llc | 4.31% | 13,018,965 | $26,428,499 | $29,943,619 | +$3,515,120 | +13.30% | |
| Soleus Capital Management, L.P. | 0.76% | 10,875,000 | $22,076,250 | $25,012,500 | +$2,936,250 | +13.30% | |
| Trails Edge Capital Partners, Lp | 2.92% | 9,051,318 | $18,374,176 | $20,818,031 | +$2,443,855 | +13.30% | |
| Fairmount Funds Management Llc | 1.16% | 8,625,000 | $17,508,750 | $19,837,500 | +$2,328,750 | +13.30% | |
| Blackrock, Inc. | 0.00% | 7,768,057 | $15,769,155 | $17,866,531 | +$2,097,376 | +13.30% | |
| Adar1 Capital Management, Llc | 0.70% | 7,387,205 | $14,996,026 | $16,990,572 | +$1,994,546 | +13.30% | |
| Blackstone Inc. | 0.04% | 5,938,276 | $12,054,700 | $13,658,035 | +$1,603,335 | +13.30% | |
| Siren, L.L.C. | 0.24% | 5,850,000 | $11,875,500 | $13,455,000 | +$1,579,500 | +13.30% | |
| Commodore Capital Lp | 0.65% | 5,397,488 | $10,956,901 | $12,414,222 | +$1,457,321 | +13.30% | |
| Vanguard Capital Management Llc | 0.00% | 4,935,354 | $10,018,769 | $11,351,314 | +$1,332,545 | +13.30% | |
| Millennium Management Llc | 0.01% | 4,028,102 | $8,177,047 | $9,264,635 | +$1,087,588 | +13.30% | |
| Saturn V Capital Management Lp | 1.13% | 3,869,056 | $7,854,184 | $8,898,829 | +$1,044,645 | +13.30% | |
| Kalehua Capital Management Llc | 4.46% | 3,821,890 | $7,758,437 | $8,790,347 | +$1,031,910 | +13.30% | |
| Spruce Street Capital Lp | 1.43% | 3,581,603 | $7,270,654 | $8,237,687 | +$967,033 | +13.30% | |
| Squadron Capital Management Llc | 2.08% | 3,000,000 | $6,090,000 | $6,900,000 | +$810,000 | +13.30% | |
| Nantahala Capital Management, Llc | 0.33% | 2,701,863 | $5,484,782 | $6,214,285 | +$729,503 | +13.30% | |
| Geode Capital Management, Llc | 0.00% | 2,607,129 | $5,293,608 | $5,996,397 | +$702,789 | +13.28% | |
| State Street Corp | 0.00% | 1,909,101 | $3,875,475 | $4,390,932 | +$515,457 | +13.30% | |
| Summittx Capital, L.P. | 0.10% | 1,780,262 | $3,613,932 | $4,094,603 | +$480,671 | +13.30% | |
| Integral Health Asset Management, Llc | 0.11% | 1,350,000 | $2,740,500 | $3,105,000 | +$364,500 | +13.30% | |
| Northern Trust Corp | 0.00% | 878,585 | $1,783,527 | $2,020,745 | +$237,218 | +13.30% | |
| Vanguard Portfolio Management Llc | 0.00% | 809,490 | $1,643,265 | $1,861,827 | +$218,562 | +13.30% | |
| Two Sigma Investments, Lp | 0.00% | 806,264 | $1,636,716 | $1,854,407 | +$217,691 | +13.30% | |
| Sphera Funds Management Ltd. | 0.19% | 649,309 | $1,318,097 | $1,493,411 | +$175,314 | +13.30% | |
| Vanguard Fiduciary Trust Co | 0.00% | 607,260 | $1,232,738 | $1,396,698 | +$163,960 | +13.30% | |
| Kennondale Capital Management Llc | 0.77% | 565,983 | $1,148,945 | $1,301,761 | +$152,816 | +13.30% | |
| Aqr Capital Management Llc | 0.00% | 468,154 | $950,353 | $1,076,754 | +$126,401 | +13.30% | |
| Nuveen, Llc | 0.00% | 425,492 | $863,749 | $978,632 | +$114,883 | +13.30% | |
| Stonepine Capital Management, Llc | 0.61% | 396,179 | $804,243 | $911,212 | +$106,969 | +13.30% | |
| Seven Fleet Capital Management Lp | 0.12% | 346,900 | $704,207 | $797,870 | +$93,663 | +13.30% | |
| Bank Of New York Mellon Corp | 0.00% | 303,126 | $615,346 | $697,190 | +$81,844 | +13.30% | |
| Jpmorgan Chase & Co | 0.00% | 316,574 | $610,988 | $728,120 | +$117,132 | +19.17% | |
| Charles Schwab Investment Management Inc | 0.00% | 275,041 | $558,333 | $632,594 | +$74,261 | +13.30% | |
| Rangeley Capital, Llc | 0.42% | 220,000 | $446,600 | $506,000 | +$59,400 | +13.30% | |
| Ubs Group Ag | 0.00% | 204,654 | $415,448 | $470,704 | +$55,256 | +13.30% | |
| Blair William & Co/Il | 0.00% | 156,080 | $316,842 | $358,984 | +$42,142 | +13.30% | |
| Alps Advisors Inc | 0.00% | 134,002 | $272,024 | $308,205 | +$36,181 | +13.30% | |
| Deutsche Bank Ag\ | 0.00% | 126,677 | $257,154 | $291,357 | +$34,203 | +13.30% | |
| Jones Financial Companies Lllp | 0.00% | 128,491 | $245,418 | $295,529 | +$50,111 | +20.42% | |
| Rhumbline Advisers | 0.00% | 120,014 | $243,622 | $276,032 | +$32,410 | +13.30% | |
| Morgan Stanley | 0.00% | 114,006 | $231,432 | $262,214 | +$30,782 | +13.30% | |
| Bank Of America Corp | 0.00% | 108,024 | $219,288 | $248,455 | +$29,167 | +13.30% | |
| Fmr Llc | 0.00% | 103,727 | $210,566 | $238,572 | +$28,006 | +13.30% | |
| Wells Fargo & Company/Mn | 0.00% | 101,841 | $206,737 | $234,234 | +$27,497 | +13.30% | |
| Price T Rowe Associates Inc | 0.00% | 99,632 | $203,000 | $229,154 | +$26,154 | +12.88% | |
| Citadel Advisors Llc | 0.00% | 74,349 | $150,928 | $171,003 | +$20,075 | +13.30% | |
| Ieq Capital, Llc | 0.00% | 68,511 | $139,078 | $157,575 | +$18,497 | +13.30% | |
| Metlife Investment Management, Llc | 0.00% | 62,524 | $126,924 | $143,805 | +$16,881 | +13.30% | |
| Invesco Ltd. | 0.00% | 62,103 | $126,069 | $142,837 | +$16,768 | +13.30% | |
| Citigroup Inc | 0.00% | 56,090 | $113,863 | $129,007 | +$15,144 | +13.30% |
Frequently asked questions about IKT
Who owns the most IKT stock?
The largest holders of IKT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for INHIBIKASE THERAPEUTICS INC (IKT).
Is IKT widely held by superinvestors?
Many widely followed stocks like IKT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly IKT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.